{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:16:04Z","timestamp":1783210564607,"version":"3.54.6"},"reference-count":164,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400479"],"award-info":[{"award-number":["82400479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2025RCZXZK47"],"award-info":[{"award-number":["2025RCZXZK47"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.livres.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:48:55Z","timestamp":1780156135000},"page":"151-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-coding RNA networks in metabolic dysfunction-associated steatotic liver disease: Mechanisms and therapeutic perspectives"],"prefix":"10.1016","volume":"10","author":[{"given":"Ruizhe","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4609-5981","authenticated-orcid":false,"given":"Siying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8688-9925","authenticated-orcid":false,"given":"Xiyang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2026.05.002_bib1","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr Biol"},{"key":"10.1016\/j.livres.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/JCMA.0000000000000230","article-title":"CircularRNA as novel biomarkers in liver diseases","volume":"83","author":"Chien","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.livres.2026.05.002_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2026.05.002_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-98489-9","article-title":"Global burden trends and forecasts for MAFLD in adolescents and young adults from 1990 to 2021","volume":"15","author":"Ruan","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2026.05.002_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.livres.2026.05.002_bib8","first-page":"10","article-title":"Investigating the role of non-coding RNA in non-alcoholic fatty liver disease","volume":"10","author":"Zailaie","year":"2024","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.livres.2026.05.002_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathol-042320-115255","article-title":"Long noncoding RNAs and human liver disease","volume":"17","author":"DiStefano","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.livres.2026.05.002_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1035159","article-title":"Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications","volume":"13","author":"Yepmo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.livres.2026.05.002_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/cells15050464","article-title":"Peroxisome proliferator-activated receptor \u03b2\/\u03b4: a link between metabolism, inflammation, and fibrosis in metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Palomer","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.05.002_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.gtc.2025.09.003","article-title":"Biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"55","author":"De","year":"2026","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.livres.2026.05.002_bib13","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/ijms26041778","article-title":"Current therapeutic landscape for metabolic dysfunction-associated steatohepatitis","volume":"26","author":"Devasia","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.05.002_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41575-025-01162-9","article-title":"Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models","volume":"23","author":"Leslie","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2026.05.002_bib16","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1038\/s41467-025-63351-z","article-title":"Helicobacter hepaticus promotes hepatic steatosis through CdtB-induced mitochondrial stress and lipid metabolism reprogramming","volume":"16","author":"Jin","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2026.05.002_bib17","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1038\/s41591-025-03799-0","article-title":"Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"31","author":"Jara","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2026.05.002_bib18","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12020-021-02716-y","article-title":"Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis","volume":"73","author":"He","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.livres.2026.05.002_bib20","doi-asserted-by":"crossref","first-page":"13647","DOI":"10.1007\/s00210-025-04257-x","article-title":"Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement","volume":"398","author":"Bhattacharya","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.livres.2026.05.002_bib21","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1053\/j.gastro.2022.01.058","article-title":"Nonalcoholic fatty liver disease and the gut-liver axis: exploring an undernutrition perspective","volume":"162","author":"Bauer","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.05.002_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/biomedicines14010120","article-title":"MicroRNAs as key regulators in the progression of metabolic dysfunction-associated steatotic liver disease: a bioinformatics analysis","volume":"14","author":"Locatelli","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.livres.2026.05.002_bib23","doi-asserted-by":"crossref","first-page":"load044","DOI":"10.1093\/lifemeta\/load044","article-title":"Regulation of hepatic lipid metabolism by intestine epithelium-derived exosomes","volume":"2","author":"Feng","year":"2023","journal-title":"Life Metab"},{"key":"10.1016\/j.livres.2026.05.002_bib24","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib25","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.05.002_bib26","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1038\/s41591-023-02539-6","article-title":"Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis","volume":"29","author":"Sanyal","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2026.05.002_bib27","doi-asserted-by":"crossref","first-page":"367 (e5)","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.05.002_bib28","doi-asserted-by":"crossref","first-page":"379 (e16)","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.05.002_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.livres.2025.10.004","article-title":"Resmetirom and beyond: a new era in MASLD therapeutics","volume":"9","author":"Johnson-Moore","year":"2025","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2026.05.002_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/ajhp\/zxag095","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): integrating metabolic and hepatic management into pharmacy practice","author":"Knorr","year":"2026","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.livres.2026.05.002_bib31","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v17.i2.113149","article-title":"Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: pathophysiology, diagnosis, and emerging therapeutic strategies","volume":"17","author":"Suresh","year":"2026","journal-title":"World J Diabetes"},{"key":"10.1016\/j.livres.2026.05.002_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70225","article-title":"Metabolic dysfunction-associated steatohepatitis diagnosis and management in Germany: insights from an expert consensus panel","volume":"45","author":"Kim","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2026.05.002_bib33","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.livres.2026.05.002_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.livres.2026.05.002_bib35","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2174\/0929867329666220801161536","article-title":"The role of miRNAs in metabolic diseases","volume":"30","author":"Macvanin","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.livres.2026.05.002_bib36","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1101\/gad.1706508","article-title":"Chromatin structure analyses identify miRNA promoters","volume":"22","author":"Ozsolak","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.livres.2026.05.002_bib37","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.livres.2026.05.002_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","article-title":"microRNA regulation of inflammatory responses","volume":"30","author":"O\u2019Connell","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.livres.2026.05.002_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2010.09.027","article-title":"MicroRNA functions in stress responses","volume":"40","author":"Leung","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.livres.2026.05.002_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNA biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.livres.2026.05.002_bib41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.livres.2026.05.002_bib42","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.livres.2026.05.002_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.livres.2026.05.002_bib44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.devcel.2026.01.010","article-title":"Noncanonical open reading frames from lncRNAs encode functional micropeptides that help shape agronomic traits in rice","volume":"61","author":"Cheng","year":"2026","journal-title":"Dev Cell"},{"key":"10.1016\/j.livres.2026.05.002_bib45","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1080\/15476286.2021.1871816","article-title":"A chromatin-associated splicing isoform of OIP5-AS1 acts in cis to regulate the OIP5 oncogene","volume":"18","author":"Wanowska","year":"2021","journal-title":"RNA Biol"},{"key":"10.1016\/j.livres.2026.05.002_bib46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","article-title":"The therapeutic potential of circular RNAs","volume":"26","author":"O\u2019Leary","year":"2025","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.livres.2026.05.002_bib47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.livres.2026.05.002_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ncrna.2025.12.005","article-title":"The circular RNA landscape: biogenesis, functions, identification pipelines, and biomedical applications","volume":"18","author":"Baiddou","year":"2026","journal-title":"Noncoding RNA Res"},{"key":"10.1016\/j.livres.2026.05.002_bib49","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.gendis.2022.11.018","article-title":"The emerging role of snoRNAs in human disease","volume":"10","author":"Zhang","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.livres.2026.05.002_bib50","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.3390\/ijms27062685","article-title":"piRNA: molecular mechanisms from germline silencing to somatic regulation and roles in disease","volume":"27","author":"Zhang","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.05.002_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108153","article-title":"tRNA-derived small RNAs in pulmonary diseases: regulatory functions and clinical prospects","volume":"226","author":"Wang","year":"2026","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.livres.2026.05.002_bib52","first-page":"1227","article-title":"Biological function of tRNA-derived small RNA and its expression and clinical significance in liver diseases","volume":"41","author":"Li","year":"2025","journal-title":"J Clin Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110402","article-title":"miRNAs, lncRNAs, circRNAs and piRNAs in nonalcoholic fatty liver disease: past, present and future","volume":"26","author":"Lucaciu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.05.002_bib54","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1038\/s41467-021-25457-y","article-title":"Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis","volume":"12","author":"Sletten","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2026.05.002_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2026.107319","article-title":"Cross-organ communication based on non-coding RNA networks leads to cognitive dysfunction in mice","volume":"221","author":"Dunkel","year":"2026","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.livres.2026.05.002_bib56","doi-asserted-by":"crossref","unstructured":"Yin X, Du Z, Jiang S, et al. RNA regulatory networks: key hubs in the panorama of cancer and emerging therapeutic targets. MedComm (2020). 2026;7:e70586. https:\/\/doi.org\/10.1002\/mco2.70586.","DOI":"10.1002\/mco2.70586"},{"key":"10.1016\/j.livres.2026.05.002_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41420-025-02833-x","article-title":"CircZBTB46 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miRNA-326\/FGF1 axis","volume":"12","author":"Zeng","year":"2026","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.livres.2026.05.002_bib58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.livres.2026.05.002_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","article-title":"MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis","volume":"129","author":"Su","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.livres.2026.05.002_bib60","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.livres.2026.05.002_bib61","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.livres.2026.05.002_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5194\/aab-64-103-2021","article-title":"Regulation of microRNA-33, SREBP and ABCA1 genes in a mouse model of high cholesterol","volume":"64","author":"Zhang","year":"2021","journal-title":"Arch Anim Breed"},{"key":"10.1016\/j.livres.2026.05.002_bib63","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1038\/ncomms3883","article-title":"MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice","volume":"4","author":"Horie","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2026.05.002_bib64","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.tem.2018.04.004","article-title":"miR-33: a metabolic conundrum","volume":"29","author":"N\u00e4\u00e4r","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.livres.2026.05.002_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.148270","article-title":"Role of lncRNAs H19, KCNQ1OT1 and SRA in relation to peroxisome proliferator-activated receptor gamma in the occurrence and progression of non-alcoholic fatty pancreas disease in obese and non-obese Egyptian patients","volume":"331","author":"Zayed","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.livres.2026.05.002_bib66","article-title":"LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL)","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2026.05.002_bib67","doi-asserted-by":"crossref","first-page":"G485","DOI":"10.1152\/ajpgi.00255.2023","article-title":"Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression","volume":"327","author":"Wu","year":"2024","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2026.05.002_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1801","article-title":"A novel peptide encoded by circ-SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac-mediated CD36 transcription in NAFLD","volume":"14","author":"Wang","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.livres.2026.05.002_bib69","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/gutjnl-2016-312869","article-title":"miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression","volume":"67","author":"Hanin","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.livres.2026.05.002_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149419","article-title":"miR-125b-5p regulates FFA-induced hepatic steatosis in L02 cells by targeting estrogen-related receptor alpha","volume":"959","author":"Gao","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.livres.2026.05.002_bib71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biom14010034","article-title":"MiR-192-5p ameliorates hepatic lipid metabolism in non-alcoholic fatty liver disease by targeting Yy1","volume":"14","author":"Ma","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.livres.2026.05.002_bib72","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/cells8101298","article-title":"MicroRNA-29a suppresses CD36 to ameliorate high fat diet-induced steatohepatitis and liver fibrosis in mice","volume":"8","author":"Lin","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.05.002_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2024.109717","article-title":"Hepatic miR-363 promotes nonalcoholic fatty liver disease by suppressing INSIG1","volume":"134","author":"Wang","year":"2024","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.livres.2026.05.002_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156266","article-title":"Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1","volume":"169","author":"Lee","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.livres.2026.05.002_bib75","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1080\/21655979.2021.1960463","article-title":"Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2","volume":"12","author":"Chen","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.livres.2026.05.002_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147747","article-title":"LncRNA AK142643 promotes hepatic lipid accumulation by upregulating CD36 via interacting with IGF2BP2","volume":"887","author":"Wang","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.livres.2026.05.002_bib77","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1002\/jcp.29795","article-title":"Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXR\u03b1 transcription","volume":"235","author":"Huang","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.livres.2026.05.002_bib78","article-title":"LncRNA GAS5 knockdown mitigates hepatic lipid accumulation via regulating miR-26a-5p\/PDE4B to activate cAMP\/CREB pathway","volume":"13","author":"Xu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.livres.2026.05.002_bib79","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1080\/21655979.2022.2026858","article-title":"Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p\/NOTCH2 axis","volume":"13","author":"Cui","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.livres.2026.05.002_bib80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cbf.3495","article-title":"Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease","volume":"38","author":"Li","year":"2020","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.livres.2026.05.002_bib81","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1194\/jlr.RA120000664","article-title":"The lncRNA Gm15622 stimulates SREBP-1c expression and hepatic lipid accumulation by sponging the miR-742-3p in mice","volume":"61","author":"Ma","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.livres.2026.05.002_bib82","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.3390\/nu13092952","article-title":"Coffee restores expression of lncRNAs involved in steatosis and fibrosis in a mouse model of NAFLD","volume":"13","author":"Di Mauro","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2026.05.002_bib83","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/jcmm.14818","article-title":"Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.livres.2026.05.002_bib84","article-title":"Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs","volume":"9","author":"El Sobky","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.livres.2026.05.002_bib85","article-title":"LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a\/PPAR\u03b3 axis in non-alcoholic fatty liver disease","volume":"39:BSR20181722","author":"Liu","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.livres.2026.05.002_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110190","article-title":"LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p\/ROCK1 axis","volume":"90","author":"Guo","year":"2022","journal-title":"Cell Signal"},{"key":"10.1016\/j.livres.2026.05.002_bib87","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12967-020-02225-y","article-title":"Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2\/AKT pathway","volume":"18","author":"Chi","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.livres.2026.05.002_bib88","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1111\/liv.14629","article-title":"LncRNA NEAT1: shedding light on mechanisms and opportunities in liver diseases","volume":"40","author":"Bu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2026.05.002_bib89","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5152\/tjg.2025.24191","article-title":"LncRNA SNHG4 regulates lipid metabolism and inflammation in non-alcoholic fatty liver disease by targeting miR-34b-5p\/XIAP axis","volume":"36","author":"Ding","year":"2025","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.livres.2026.05.002_bib90","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41419-021-04090-z","article-title":"Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1\/AMPK signaling through targeting miR-206","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.05.002_bib91","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.18632\/aging.104081","article-title":"Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179\/miR-188-3p\/GPX4 signaling","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.livres.2026.05.002_bib92","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2026.05.002_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101581","article-title":"MicroRNAs in non-alcoholic fatty liver disease: progress and perspectives","volume":"65","author":"Hochreuter","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.livres.2026.05.002_bib94","doi-asserted-by":"crossref","first-page":"16137","DOI":"10.1073\/pnas.1205951109","article-title":"Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor \u03b2-Klotho","volume":"109","author":"Fu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2026.05.002_bib95","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cbin.11022","article-title":"MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-\u03b21\/Smad3 pathway in hepatic stellate cells","volume":"42","author":"Feili","year":"2018","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.livres.2026.05.002_bib96","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S2468-1253(20)30252-1","article-title":"A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study","volume":"5","author":"Harrison","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib97","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.livres.2026.05.002_bib98","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12967-021-02769-7","article-title":"LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-\u03baB\/JNK pathway by endoplasmic reticulum stress","volume":"19","author":"Ye","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.livres.2026.05.002_bib99","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.31428","article-title":"An endoplasmic reticulum stress-microRNA-26a feedback circuit in NAFLD","volume":"73","author":"Xu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.05.002_bib100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/iub.2221","article-title":"Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway","volume":"72","author":"Teimouri","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.livres.2026.05.002_bib101","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.18632\/aging.102721","article-title":"Targeting of miR-96-5p by catalpol ameliorates oxidative stress and hepatic steatosis in LDLr-\/- mice via p66shc\/cytochrome C cascade","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.livres.2026.05.002_bib102","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1096\/fj.201900643RRR","article-title":"Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway","volume":"33","author":"Chen","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.livres.2026.05.002_bib103","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1159\/000447917","article-title":"Decreased MiR-155 level in the peripheral blood of non-alcoholic fatty liver disease patients may serve as a biomarker and may influence LXR activity","volume":"39","author":"Wang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.livres.2026.05.002_bib104","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2026.05.002_bib105","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41374-021-00626-1","article-title":"Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH","volume":"101","author":"Bala","year":"2021","journal-title":"Lab Invest"},{"key":"10.1016\/j.livres.2026.05.002_bib106","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141513","article-title":"Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis","volume":"131","author":"He","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.livres.2026.05.002_bib107","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.30645","article-title":"MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes","volume":"70","author":"He","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.05.002_bib108","article-title":"Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability","volume":"6","author":"Yan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2026.05.002_bib109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.trsl.2017.09.001","article-title":"Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells","volume":"190","author":"Leti","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.livres.2026.05.002_bib110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s40001-024-01817-4","article-title":"Competitive adsorption of microRNA-532-3p by circular RNA SOD2 activates Thioredoxin Interacting Protein\/NLR family pyrin domain containing 3 pathway and promotes pyroptosis of non-alcoholic fatty hepatocytes","volume":"29","author":"Chen","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.livres.2026.05.002_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119071","article-title":"miR-125b promotes the NF-\u03baB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3","volume":"270","author":"Zhang","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2026.05.002_bib112","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte-derived exosomal microRNA 192-5p activates macrophages through Rictor\/Akt\/Forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.05.002_bib113","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","article-title":"MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-\u03baB-TNF\u03b1 pathway","volume":"70","author":"Zhang","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib114","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-024-05283-8","article-title":"Exosomes regulate SIRT3-related autophagy by delivering miR-421 to regulate macrophage polarization and participate in OSA-related NAFLD","volume":"22","author":"Yang","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.livres.2026.05.002_bib115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biocel.2015.04.016","article-title":"Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK\/AKT pathway","volume":"64","author":"Hur","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.livres.2026.05.002_bib116","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41418-023-01183-4","article-title":"GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p\/MARCH7\/NLRP3 axis-mediated pyroptosis","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.livres.2026.05.002_bib117","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10616-023-00614-x","article-title":"LncRNA HOTAIR accelerates free fatty acid-induced inflammatory response in HepG2 cells by recruiting SRSF1 to stabilize MLXIPL mRNA","volume":"76","author":"Guo","year":"2024","journal-title":"Cytotechnology"},{"key":"10.1016\/j.livres.2026.05.002_bib118","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/cells10081883","article-title":"Long non-coding RNAs involved in progression of non-alcoholic fatty liver disease to steatohepatitis","volume":"10","author":"Atanasovska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.05.002_bib119","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7150\/thno.50281","article-title":"Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.livres.2026.05.002_bib120","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib121","doi-asserted-by":"crossref","first-page":"C588","DOI":"10.1152\/ajpcell.00253.2022","article-title":"Circulating miRNAs associated with nonalcoholic fatty liver disease","volume":"324","author":"Atic","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.livres.2026.05.002_bib122","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","article-title":"miRNAs in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"69","author":"Liu","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib123","doi-asserted-by":"crossref","first-page":"37082","DOI":"10.1074\/jbc.M113.517953","article-title":"The autoregulatory feedback loop of microRNA-21\/programmed cell death protein 4\/activation protein-1 (MiR-21\/PDCD4\/AP-1) as a driving force for hepatic fibrosis development","volume":"288","author":"Zhang","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.livres.2026.05.002_bib124","first-page":"2201","article-title":"Role and mechanisms of action of microRNA-21 as regards the regulation of the WNT\/\u03b2-catenin signaling pathway in the pathogenesis of non-alcoholic fatty liver disease","volume":"44","author":"Wang","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.livres.2026.05.002_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2019.01.018","article-title":"LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6","volume":"94","author":"Huang","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.livres.2026.05.002_bib126","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1684\/ecn.2019.0432","article-title":"lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506\/GLI3","volume":"30","author":"Jin","year":"2019","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.livres.2026.05.002_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100584","article-title":"Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p\/c-Jun\/SREBP-1c pathway","volume":"27","author":"Jin","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib128","first-page":"2455","article-title":"Lnc-LFAR1 affects intrahepatic cholangiocarcinoma proliferation, invasion, and EMT by regulating the TGF\u03b2\/Smad signaling pathway","volume":"12","author":"Chen","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.livres.2026.05.002_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102807","article-title":"Circular RNA encoding relaxin-2 as a potential therapy for liver fibrosis","volume":"37","author":"Zhong","year":"2026","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.livres.2026.05.002_bib130","article-title":"MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.05.002_bib131","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3390\/cells9081767","article-title":"MicroRNA-221: a fine tuner and potential biomarker of chronic liver injury","volume":"9","author":"Markovic","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.05.002_bib132","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.31658","article-title":"Myeloid-cell-specific IL-6 signaling promotes microRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis","volume":"74","author":"Hou","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.05.002_bib133","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1002\/jcp.28450","article-title":"Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease","volume":"234","author":"Shen","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.livres.2026.05.002_bib134","doi-asserted-by":"crossref","DOI":"10.5493\/wjem.v15.i4.107316","article-title":"Gut microbiota and metabolic-associated steatosis liver disease: unveiling mechanisms and opportunities for therapeutic intervention","volume":"15","author":"Rusman","year":"2025","journal-title":"World J Exp Med"},{"key":"10.1016\/j.livres.2026.05.002_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1734182","article-title":"Non-coding RNAs in the viral host-pathogen interaction: molecular regulation and therapeutic potential","volume":"15","author":"Yamin","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.livres.2026.05.002_bib136","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.3390\/ijms26178633","article-title":"MASLD under the microscope: how microRNAs and microbiota shape hepatic metabolic disease progression","volume":"26","author":"Asero","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.05.002_bib137","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4014\/jmb.2002.02059","article-title":"Lactobacillus casei LC01 regulates intestinal epithelial permeability through miR-144 targeting of OCLN and ZO1","volume":"30","author":"Hou","year":"2020","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.livres.2026.05.002_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104200","article-title":"The importance of interaction between MicroRNAs and gut microbiota in several pathways","volume":"144","author":"Behrouzi","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.livres.2026.05.002_bib139","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/nu18060953","article-title":"Broccoli-derived exosome-like nanoparticles alleviates metabolic dysfunction-associated steatotic liver disease through modulating the gut-liver axis","volume":"18","author":"Zhang","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2026.05.002_bib140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.livres.2026.05.002_bib141","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-023-00725-w","article-title":"Circulating non-coding RNAs in chronic kidney disease and its complications","volume":"19","author":"van Zonneveld","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.livres.2026.05.002_bib142","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","article-title":"Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment","volume":"35","author":"Wang","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2026.05.002_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300631","article-title":"Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL\/NASH: impact of LPS\/TLR-4\/FoxO3 pathway","volume":"357","author":"Samy","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.livres.2026.05.002_bib144","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","article-title":"Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity","volume":"171","author":"Ying","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.livres.2026.05.002_bib145","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1053\/j.gastro.2017.08.013","article-title":"Metabolic circuit involving free fatty acids, microRNA 122, and triglyceride synthesis in liver and muscle tissues","volume":"153","author":"Chai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2026.05.002_bib146","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00216-011-5001-8","article-title":"MicroRNAs as biomarkers of disease onset","volume":"401","author":"Ciesla","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.livres.2026.05.002_bib147","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids--the mix of hormones and biomarkers","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.livres.2026.05.002_bib148","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12072-020-10096-0","article-title":"Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism","volume":"14","author":"Li","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2026.05.002_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2023.2290769","article-title":"Circular RNAs in non-alcoholic fatty liver disease: functions and clinical significance","volume":"21","author":"Zeng","year":"2024","journal-title":"RNA Biol"},{"key":"10.1016\/j.livres.2026.05.002_bib150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/nar\/gkv1206","article-title":"Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides","volume":"44","author":"Lennox","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.livres.2026.05.002_bib151","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41419-020-2293-7","article-title":"Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy","volume":"11","author":"Jin","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.05.002_bib152","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2024.11.052","article-title":"A read-through circular RNA RCRIN inhibits metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Wang","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.05.002_bib153","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12951-021-01108-8","article-title":"A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p\/miR-320a and ABCA1\/CPT1 axis","volume":"19","author":"Li","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.livres.2026.05.002_bib154","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.livres.2026.05.002_bib155","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/acs.molpharmaceut.2c00033","article-title":"Comparison of DLin-MC3-DMA and ALC-0315 for siRNA delivery to hepatocytes and hepatic stellate cells","volume":"19","author":"Ferraresso","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.livres.2026.05.002_bib156","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/pharmaceutics5030498","article-title":"Advances in lipid nanoparticles for siRNA delivery","volume":"5","author":"Tam","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.livres.2026.05.002_bib157","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2026.05.002_bib158","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.livres.2026.05.002_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123510","article-title":"Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis","volume":"324","author":"Zhang","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.livres.2026.05.002_bib160","article-title":"Ligand-tethered extracellular vesicles mediated RNA therapy for liver fibrosis","volume":"14","author":"Liu","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.livres.2026.05.002_bib161","doi-asserted-by":"crossref","first-page":"335","DOI":"10.62347\/RGTY8619","article-title":"miRNA regulatory networks as precision diagnostic and therapeutic targets in pulmonary arterial hypertension: from molecular cascades to clinical translation","volume":"15","author":"Li","year":"2025","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.livres.2026.05.002_bib162","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3390\/ijms27021066","article-title":"The interplay between cellular senescence and lipid metabolism in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"27","author":"Mastoridou","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.05.002_bib163","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.livres.2025.04.001","article-title":"The revolutionary role of machine learning in predicting, diagnosing, and treating liver disease","volume":"9","author":"Huang","year":"2025","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2026.05.002_bib164","doi-asserted-by":"crossref","first-page":"bbac411","DOI":"10.1093\/bib\/bbac411","article-title":"ncRNAInter: a novel strategy based on graph neural network to discover interactions between lncRNA and miRNA","volume":"23","author":"Zhang","year":"2022","journal-title":"Brief Bioinform"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568426000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568426000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:29:22Z","timestamp":1783207762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568426000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":164,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2542568426000267"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2026.05.002","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNA networks in metabolic dysfunction-associated steatotic liver disease: Mechanisms and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Third Affiliated Hospital of Sun Yat-Sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}